Acute vigorous exercise attenuates sensitivity of platelets to nitric oxide.

Abstract:

:We tested whether inhibition of platelet activation by nitric oxide (NO) might be altered by strenuous exercise. Sixteen healthy male non-smokers, aged 20-26 years, underwent treadmill testing. All subjects reached Bruce stage IV without chest pain or abnormal ST-T wave changes. Platelet aggregation by Born's method and cyclic GMP accumulation in the washed platelets were determined before and immediately after exercise. Dose-response curves for platelet aggregation by collagen were constructed both in the absence and presence of 2 microM SIN-1, an NO donor, to quantify the antiaggregation effects of NO. After exercise, platelet aggregation by collagen was modestly enhanced and inhibition of platelet aggregation by SIN-1 was significantly attenuated by exercise. This attention was accompanied by a blunted cyclic GMP response of the platelets to the NO donor. We conclude that impaired sensitivity of the platelets to NO, in addition to the enhancement of platelet aggregation, may partially explain the epidemiological evidence that acute strenuous exercise precipitates coronary events.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Sakita S,Kishi Y,Numano F

doi

10.1016/s0049-3848(97)00162-x

subject

Has Abstract

pub_date

1997-09-01 00:00:00

pages

461-71

issue

5

eissn

0049-3848

issn

1879-2472

pii

S004938489700162X

journal_volume

87

pub_type

杂志文章
  • Global fibrinolytic capacity in children on dialysis.

    abstract:UNLABELLED:Disturbances of coagulation and fibrinolysis have been reported in patients with chronic uremia. Studies of different coagulation and fibrinolysis parameters in regularly dialyzed patients have yielded conflicting results. Global fibrinolytic capacity (GFC) examines the function of the entire fibrinolytic sy...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.08.014

    authors: Agras PI,Baskin E,Cengiz N,Kirazli S,Saatci U,Ozbek N

    更新日期:2005-01-01 00:00:00

  • High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications.

    abstract:INTRODUCTION:Patients with type 1 diabetes have high risk of developing microvascular complications, and microangiopathy contributes to premature cardiovascular disease in this population. The role that microvesicles (MVs) may play in the development of microangiopathy in type 1 diabetes remains unclear. MATERIALS AND...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.08.012

    authors: Bergen K,Mobarrez F,Jörneskog G,Wallén H,Tehrani S

    更新日期:2020-12-01 00:00:00

  • Effects of insulin on platelet and leukocyte activity in whole blood.

    abstract::Diabetes mellitus (DM) is associated with platelet and leukocyte dysfunction. Previous observations with regard to insulin effects on platelet and leukocyte function are less than consistent. We thus investigated the effects of insulin on platelets and leukocytes, as well as on platelet-leukocyte interactions in whole...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(02)00306-7

    authors: Hu H,Hjemdahl P,Li N

    更新日期:2002-09-01 00:00:00

  • The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with the level of decrease on diastolic blood pressure in essential hypertension patients treated by angiotensin-converting enzyme inhibitor.

    abstract:OBJECTIVES:Elevated plasma homocysteine has been implicated as a risk factor for hypertension. C677T polymorphism in methylenetetrahydrofolate reductase gene (MTHFR) is a major determinant of hyperhomocysteinemia, which results in endothelial dysfunction. Angiotensin-converting enzyme (ACE) inhibitors appear to remedy ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.04.005

    authors: Jiang S,Hsu YH,Xu X,Xing H,Chen C,Niu T,Zhang Y,Peng S,Xu X

    更新日期:2004-01-01 00:00:00

  • Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein.

    abstract::Activation of human platelets by PAF was augmented by C-reactive protein, an acute phase plasma protein. The concentration of PAF required for irreversible activation (secondary aggregation of platelet and release of serotonin) was decreased to 1/10 in the presence of C-reactive protein (CRP). The presence of CRP stim...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90361-0

    authors: Kohayakawa M,Inoue K

    更新日期:1986-03-01 00:00:00

  • Point-of-care antithrombotic monitoring in children.

    abstract:INTRODUCTION:The use of oral anticoagulant therapy is increasing in children. Managing anticoagulant therapy in children presents unique challenges, including poor venous access. The advent of point-of-care (POC) monitoring of anticoagulant therapy offers a potential solution to this challenge. This paper reviews the p...

    journal_title:Thrombosis research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.thromres.2005.03.008

    authors: Newall F,Bauman M

    更新日期:2006-01-01 00:00:00

  • Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit.

    abstract::An extensive study of the pharmacokinetics and the pharmacokinetics of the profibrinolytic activity of Defibrotide (D) in the rabbit has been made. a two compartment model was used to describe D's pharmacokinetics. The parameters of drug disposition and the rate constant of release from tissues to central compartment ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90391-2

    authors: Pescador R,Mantovani M,Prino G,Madonna M

    更新日期:1983-04-01 00:00:00

  • Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.

    abstract::A semi-synthetic 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine (alkylacetyl-GPC) was shown to be highly species selective in its capacity to cause platelet aggregation and serotonin release. No effects were elicited on the rat or mouse platelets while platelets from human, dog, cat, rabbit, guinea pig and horse were ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90234-1

    authors: Namm DH,Tadepalli AS,High JA

    更新日期:1982-02-15 00:00:00

  • Alleviation of synovitis caused by joint instability with application of platelet-rich plasma.

    abstract:INTRODUCTION:Synovitis is an early set and persistent change during the progression of osteoarthritis, which causes symptoms such as pain and swelling of the joints. Platelet-rich plasma (PRP) can release quantities of growth factors and cytokines, and is proved effected in promoting restoration of multiple soft tissue...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2019.11.017

    authors: Yin J,Xu Z,Liu J

    更新日期:2020-02-01 00:00:00

  • Red blood cell distribution width (RDW) and long-term survival in patients with ST elevation myocardial infarction.

    abstract:INTRODUCTION:High RDW values are associated with adverse prognosis in many clinical conditions including short and medium term outcome of patients with ST Elevation Myocardial Infarction (STEMI). The aim of the present study was to evaluate the association between RDW and long term mortality in STEMI patients undergoin...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.08.016

    authors: Arbel Y,Shacham Y,Finkelstein A,Halkin A,Milwidsky A,Berliner S,Ziv-Baran T,Revivo M,Herz I,Keren G,Banai S

    更新日期:2014-11-01 00:00:00

  • Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.

    abstract:BACKGROUND:Whether antibodies directed to β2-Glycoprotein I (aβ2GPI) are responsible for LA activity is not well defined. However, in the absence of such antibodies the molecule responsible for LA phenomenon is unknown. OBJECTIVE:The aim of this study was the biochemical identification of the target antigen epitope of...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.11.003

    authors: Pengo V,Del Ross T,Ruffatti A,Bison E,Cattini MG,Pontara E,Testa S,Legnani C,Pozzi N,Peterle D,Acquasaliente L,De Filippis V,Denas G

    更新日期:2018-12-01 00:00:00

  • Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.

    abstract:INTRODUCTION:Animal models of thrombosis and hemostasis are critical for target validation in pharmaceutical research. Guinea pig haemostatic mechanisms, such as the platelet thrombin receptor repertoire, resemble those of humans. Measuring the performance characteristics of marketed antithrombotic drugs in guinea pig ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.03.010

    authors: Bird JE,Giancarli MR,Allegretto N,Barbera F,Wong P,Schumacher WA,Ogletree ML,Seiffert D

    更新日期:2008-01-01 00:00:00

  • The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis.

    abstract:INTRODUCTION:Procoagulant activity of heparanase has been recently described in several arterial and venous thrombotic disorders. In this study, we aimed to investigate the role of heparanase with regard to thrombus burden, thromboembolism, and treatment success with unfractionated heparin (UFH) in patients with prosth...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.09.061

    authors: Bayam E,Kalçık M,Gürbüz AS,Yesin M,Güner A,Gündüz S,Gürsoy MO,Karakoyun S,Cerşit S,Kılıçgedik A,Candan Ö,Yaman A,Özkan M

    更新日期:2018-11-01 00:00:00

  • Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs).

    abstract:BACKGROUND:Non-vitamin K antagonist oral anticoagulants (NOACs) do not need routine laboratory monitoring but measurement of drug concentration is important in emergency conditions. Specific laboratory tests are not readily available or not implemented in every hospital. Point-of-Care Tests (POCT) may bridge this gap a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.01.044

    authors: Padayattil Jose S,Banzato A,Carraro P,Haleh A,Rossi K,Nante G,Denas G,Zoppellaro G,Pengo V

    更新日期:2018-03-01 00:00:00

  • Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.

    abstract:INTRODUCTION:Coagulation factor XIII (FXIII) is a fibrin-stabilizing factor, which contributes to hemostasis, wound healing, and maintenance of pregnancy. Accordingly, patients with congenital FXIII deficiency manifest a life-long bleeding tendency, abnormal wound healing and recurrent miscarriage. In order to understa...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2012.05.003

    authors: Souri M,Yee VC,Fujii N,Ichinose A

    更新日期:2012-09-01 00:00:00

  • Central venous catheter-related thrombosis in children and adults.

    abstract::Central venous catheters (CVC) have revolutionized the care of patients requiring long-term venous access. With increasing use of CVCs, the incidence of catheter-related thrombosis (CRT) has been on the rise. CRT constitutes 10% of all deep venous thromboses (DVT) in adults and 50-80% of all DVTs among children. The i...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2020.01.017

    authors: Citla Sridhar D,Abou-Ismail MY,Ahuja SP

    更新日期:2020-03-01 00:00:00

  • On the inhibitory effect of chloroquine on blood platelet aggregation.

    abstract::Chloroquine inhibited aggregation of rat blood platelets in a dose-dependent way. The inhibitory effect decreased, depending on the aggregation stimulus used, in the rank order of potency: ADP > thrombin > A23187. Effect of 1 millimolar chloroquine on A23187-stimulated aggregation was significantly decreased or comple...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90270-4

    authors: Jancinová V,Nosál R,Petríková M

    更新日期:1994-06-01 00:00:00

  • PO-50 - The effect of tissue factor expression on colorectal cancer cell proliferation.

    abstract:INTRODUCTION:Tissue factor (TF) is abnormally expressed in many cancers including colorectal and is associated with a poor cancer prognosis. Colorectal cancer cell lines expressing TF produce faster growing tumours. In lung cancer, TF inhibition has been shown to reduce proliferation AIM:We aimed to determine if TF ex...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(16)30183-9

    authors: Clouston HW,Lamb R,Duff S,Kirwan CC

    更新日期:2016-04-01 00:00:00

  • Platelet activation and antiplatelet therapy in sepsis: A narrative review.

    abstract::Platelet activation plays an important role in the development of sepsis. During sepsis, platelet activation leads to endothelial cell injury and promotes neutrophil extracellular trap and microthrombus formation, exacerbating septic coagulation and inflammatory reactions. The resultant induction or aggravation of dis...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2018.04.007

    authors: Wang Y,Ouyang Y,Liu B,Ma X,Ding R

    更新日期:2018-06-01 00:00:00

  • Changes in blood viscosity by heparin and argatroban.

    abstract::Anticoagulants are effective for preventing both venous and arterial thrombosis. Although antithrombotic agents have been reported to reduce thrombin formation, to our knowledge, the relation between blood viscosity (BV) and antithrombotic agents has not been examined. We examined the effects on whole BV of various do...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00359-0

    authors: Hitosugi M,Niwa M,Takatsu A

    更新日期:2001-12-01 00:00:00

  • Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.

    abstract::VKORC1 and VKORC1L1 are enzymes that both catalyze the reduction of vitamin K2,3-epoxide via vitamin K quinone to vitamin K hydroquinone. VKORC1 is the key enzyme of the classical vitamin K cycle by which vitamin K-dependent (VKD) proteins are γ-carboxylated by the hepatic γ-glutamyl carboxylase (GGCX). In contrast, t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2015.01.025

    authors: Caspers M,Czogalla KJ,Liphardt K,Müller J,Westhofen P,Watzka M,Oldenburg J

    更新日期:2015-05-01 00:00:00

  • Glycoprotein IIb-IIIa complex in platelets of patients and heterozygotes of Glanzmann's thrombasthenia.

    abstract::The concentration of the glycoprotein (GP) IIb-IIIa complex in thrombasthenic platelets of 8 patients of 6 families has been estimated. In the thrombasthenic platelets of 3 patients this complex is absent (thrombasthenia type I and subtype I). In 2 patients only traces are detectable and in 3 patients GP IIb-IIIa comp...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90063-4

    authors: Herrmann FH,Meyer M,Gogstad GO,Solum NO

    更新日期:1983-12-15 00:00:00

  • Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet.

    abstract::Binding of 3H-labeled 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor; PAF) to the intact, washed canine platelet has been defined and characterized as being specific and receptor-mediated. Under the conditions described, specific binding to 2 X 10(7) canine platelets reached saturation with...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90339-8

    authors: Janero DR,Burghardt B,Burghardt C

    更新日期:1988-06-15 00:00:00

  • Anticoagulant effects of an antidiabetic drug on monocytes in vitro.

    abstract:INTRODUCTION:Monocyte- and microparticle (MP)-associated tissue factor (TF) is upregulated in diabetes. Lipopolysaccharide (LPS) induces expression of TF and alternatively spliced TF (asTF) and increases MP release from monocytes. Using LPS-stimulated TF-bearing human monocytes, we examined whether glibenclamide, a sul...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2011.07.007

    authors: Henriksson CE,Hellum M,Haug KB,Aass HC,Joø GB,Øvstebø R,Trøseid AM,Klingenberg O,Kierulf P

    更新日期:2011-11-01 00:00:00

  • Allele frequencies of two polymorphisms associated with the factor IX gene in Iranian population.

    abstract::Indirect genetic diagnosis using polymorphic DNA markers can be useful in large-scale screening programs, which is technically simpler, more rapid and amenable. The main objective of this study was to test the informativeness of two common intragenic markers (TaqI and XmnI) in Iranian haemophilia B families to detect ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.03.009

    authors: Ghandil P,Ghadiri A,Farhud D,Zeinali S

    更新日期:2004-01-01 00:00:00

  • Evaluation of annexin V as a platelet-directed thrombus targeting agent.

    abstract::Annexin V is a human phospholipid binding protein (M(r) 36,000) that binds with high affinity to activated platelets in vitro. We studied the biodistribution and thrombus binding of annexin V in rabbit and swine models of fully occlusive arterial thrombi formed 1-2 h prior to injection of annexin V. Iodinated annexin ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90224-0

    authors: Tait JF,Cerqueira MD,Dewhurst TA,Fujikawa K,Ritchie JL,Stratton JR

    更新日期:1994-09-01 00:00:00

  • Platelet activation and endogenous thrombin potential in pre-eclampsia.

    abstract:INTRODUCTION:Platelets and the coagulation system may be involved in the pathogenesis of pre-eclampsia. We investigated whether platelet and coagulation activation markers, are elevated in pre-eclampsia. MATERIALS/METHODS:Case-control study in which activated platelets, platelet-monocyte/ neutrophil aggregates, platel...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.09.013

    authors: Macey MG,Bevan S,Alam S,Verghese L,Agrawal S,Beski S,Thuraisingham R,MacCallum PK

    更新日期:2010-03-01 00:00:00

  • Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification.

    abstract::The study of the interaction between activated protein C (APC) and non-plasmatic inhibitors allowed us to demonstrate that aprotinin is a potent competitive inhibitor of APC with a Ki of 1.35 mumol/L. It was possible to adsorb immunopurified protein C (PC) activated by venom activator to insolubilized aprotinin and to...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90268-h

    authors: Taby O,Chabbat J,Steinbuch M

    更新日期:1990-07-01 00:00:00

  • Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.

    abstract:INTRODUCTION:To evaluate the pathogenetic role of tissue factor (TF), tissue factor pathway inhibitor (TFPI), and neutrophil elastase in acute respiratory distress syndrome (ARDS), as well as to test the hypothesis that TFPI levels modified by neutrophil activation are not sufficient to prevent TF-dependent intravascul...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0049-3848(03)00151-8

    authors: Gando S,Kameue T,Matsuda N,Hayakawa M,Morimoto Y,Ishitani T,Kemmotsu O

    更新日期:2003-01-25 00:00:00

  • Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer.

    abstract:INTRODUCTION:Colorectal cancer (CRC) is often complicated by thromboembolic episodes. It has been recognized that blood coagulation proteins play a role in cancer progression. An important inhibitory mechanism is provided by the protein C (PC) system consisting of PC, protein S (PS) and thrombomodulin (TM). Recently, n...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.09.011

    authors: Sierko E,Wojtukiewicz MZ,Zawadzki R,Zimnoch L,Kisiel W

    更新日期:2010-03-01 00:00:00